Literature DB >> 5094143

Effects of chronic heart failure on the capacity of glucagon to enhance contractility and adenyl cyclase activity of human papillary muscles.

R E Goldstein, C L Skelton, G S Levey, D L Glancy, G D Beiser, S E Epstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5094143     DOI： 10.1161/01.cir.44.4.638

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.

Authors:  H von der Leyen; U Mende; W Meyer; J Neumann; M Nose; W Schmitz; H Scholz; J Starbatty; B Stein; H Wenzlaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

2.  Effect of glucagon on left ventricular performance in aortic stenosis.

Authors:  J Hamer; D Gibson; J Coltart
Journal:  Br Heart J       Date:  1973-03

3.  Response of isolated human ventricular myocardium to cyclic AMP and its dibutyryl derivative.

Authors:  T Meinertz; H Nawrath; H Scholz; K Winter
Journal:  Klin Wochenschr       Date:  1974-07-15

4.  The mechanics of esophageal muscle contraction. Evidence of an inotropic effect of gastrin.

Authors:  S Cohen; F Green
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

5.  The paradox of the lack of the efficacy of digitalis in congestive heart failure with sinus rhythm.

Authors:  J Hamer
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

6.  The positive inotropic response to milrinone in isolated human and guinea pig myocardium.

Authors:  L Brown; M Näbauer; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

7.  Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1984-07

8.  Role of sodium glucose co-transporter 2 inhibitors in patients with heart failure: an elusive mechanism.

Authors:  Hafiz Imran; William Nester; Islam Y Elgendy; Marwan Saad
Journal:  Ann Med       Date:  2020-05-22       Impact factor: 4.709

Review 9.  Glucagon and heart in type 2 diabetes: new perspectives.

Authors:  Antonio Ceriello; Stefano Genovese; Edoardo Mannucci; Edoardo Gronda
Journal:  Cardiovasc Diabetol       Date:  2016-08-27       Impact factor: 9.951
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.